Illumina (ILMN) Set to Announce Earnings on Monday
Illumina (NASDAQ:ILMN) is scheduled to be releasing its earnings data on Monday, October 21st. Illumina has set its FY13 guidance at $1.68-1.72 EPS.Parties interested in participating in the company’s conference call can do so using this link.
Illumina (NASDAQ:ILMN) last released its earnings data on Tuesday, July 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. The company had revenue of $346.09 million for the quarter, compared to the consensus estimate of $331.77 million. During the same quarter in the previous year, the company posted $0.40 earnings per share. The company’s revenue for the quarter was up 23.3% on a year-over-year basis. On average, analysts expect Illumina to post $1.72 EPS for the current fiscal year and $2.03 EPS for the next fiscal year.
Shares of Illumina (NASDAQ:ILMN) opened at 82.10 on Friday. Illumina has a 52 week low of $44.78 and a 52 week high of $85.81. The stock has a 50-day moving average of $80.45 and a 200-day moving average of $72.85. The company has a market cap of $10.272 billion and a price-to-earnings ratio of 97.20.
Several analysts have recently commented on the stock. Analysts at Wedbush raised their price target on shares of Illumina from $60.00 to $65.00 in a research note to investors on Tuesday. They now have a “neutral” rating on the stock. On the ratings front, analysts at Bank of America Corp. reiterated a “buy” rating on shares of Illumina in a research note to investors on Friday, September 27th. They now have a $90.00 price target on the stock. Finally, analysts at Goldman Sachs Group Inc. raised their price target on shares of Illumina from $73.00 to $74.00 in a research note to investors on Friday, September 27th. They now have a “neutral” rating on the stock. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $74.96.
In other Illumina news, SVP Nicholas Naclerio sold 4,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $81.32, for a total value of $325,280.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.